Internal Medicine, Nephrology · Florence, SC
NPI
1770572562
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
255 Warley St
Florence, SC, 29501
Phone (843) 669-6694
Groups this clinician bills Medicare through
Medicare paid, 2024
$377K
4,982 services
Medicare patients, 2024
676
Average age 72
Drug cost, 2024
$1.7M
6,638 prescriptions
Company payments, 2025
$438
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Inderpal Singh was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 805 times for 340 patients. In total Inderpal Singh billed 4,982 services in 26 codes, and Medicare paid $377K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 805 | 340 | $11.55 | $9,300 |
| 99232 Hospital E&M - Subsequent | Facility | 762 | 229 | $57.79 | $44K |
| 90960 ESRD Related Services (not dialysis) | Office | 733 | 98 | $259.16 | $190K |
| 99214 Office E&M - Established | Office | 659 | 300 | $51.78 | $34K |
| 81002 Clinical Chemistry | Office | 632 | 294 | $3.40 | $2,149 |
| 90935 Hemodialysis | Facility | 266 | 115 | $52.44 | $14K |
| 99215 Office E&M - Established | Office | 107 | 76 | $79.94 | $8,553 |
| 90961 ESRD Related Services (not dialysis) | Office | 85 | 59 | $214.32 | $18K |
| 99222 Hospital E&M - Initial | Facility | 78 | 73 | $93.41 | $7,286 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 76 | 54 | $180.37 | $14K |
| 99205 Office E&M - New | Office | 47 | 47 | $150.29 | $7,064 |
| 99239 Hospital Discharge Management | Facility | 39 | 34 | $85.30 | $3,327 |
| 99223 Hospital E&M - Initial | Facility | 25 | 25 | $124.07 | $3,102 |
| 99204 Office E&M - New | Office | 18 | 18 | $97.10 | $1,748 |
| 90962 ESRD Related Services (not dialysis) | Office | 11 | 11 | $148.27 | $1,631 |
By year: 2022 $557K for 4,943 services; 2023 $420K for 4,365 services; 2024 $377K for 4,982 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 632 | 294 | $3.40 | $2,149 |
Medicare prescription drug claims, 2024
In 2024, the drug Inderpal Singh prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 826 prescriptions and refills. In total Inderpal Singh wrote 6,638 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 826 | 1,071 | 158 | $593K |
| Losartan Potassium Generic | 451 | 896 | 128 | $3,213 |
| Amlodipine Besylate Generic | 367 | 683 | 102 | $1,589 |
| Jardiance Empagliflozin | 338 | 433 | 73 | $254K |
| Doxazosin Mesylate Generic | 278 | 510 | 76 | $3,221 |
| Sevelamer Carbonate Generic | 277 | 328 | 68 | $42K |
| Spironolactone Generic | 264 | 456 | 76 | $2,109 |
| Metoprolol Succinate Generic | 159 | 279 | 47 | $1,876 |
| Auryxia Ferric Citrate | 145 | 163 | 26 | $241K |
| Hydralazine Hcl Generic | 135 | 244 | 36 | $1,731 |
| Furosemide Generic | 126 | 210 | 37 | $700 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 111 | 208 | 29 | $957 |
| Atorvastatin Calcium Generic | 110 | 234 | 31 | $1,262 |
| Metoprolol Tartrate Generic | 99 | 194 | 37 | $587 |
| Torsemide Generic | 93 | 175 | 30 | $1,777 |
Brand drugs: 1,897 claims; generic drugs: 4,729 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Inderpal Singh $438 ($438 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $175.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.